Search research articles
Contact Us
Filters
Showing results (11-20 of 45) with videos related to
Page
of 5
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 17, 2000
Treatment of Hodgkin's disease: current strategies of the German Hodgkin's Lymphoma Study Group
M Sieber, U Rüffer, A Josting, et al.
Der Internist
|
February 28, 2003
[Current therapeutic strategies in Hodgkin lymphoma]
S Ansén, M Sieber, K Wingbermühle, et al.
Blood
|
August 15, 2000
Prognostic factors and treatment outcome in primary progressive Hodgkin lymphoma: a report from the German Hodgkin Lymphoma Study Group
A Josting, U Rueffer, J Franklin, et al.
Annals of Hematology
|
September 12, 2002
A randomized trial of chemotherapy with carmustine, etoposide, cytarabine, and melphalan (BEAM) plus peripheral stem cell transplantation (PBSCT) vs single-agent high-dose chemotherapy followed by BEAM plus PBSCT in patients with relapsed Hodgkin's disease (HD-R2)
J-P Glossmann, A Josting, B Pfistner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 19, 2000
Treatment of primary progressive Hodgkin's and aggressive non-Hodgkin's lymphoma: is there a chance for cure?
A Josting, M Reiser, U Rueffer, et al.
Pediatric Research
|
November 1, 1995
Bone marrow fibroblasts from children with aplastic anemia exhibit reduced interleukin-6 production in response to cytokines and viral challenge
D Dilloo, R Vöhringer, A Josting, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 20, 2010
Impact of first- and second-line treatment for Hodgkin's lymphoma on the incidence of AML/MDS and NHL--experience of the German Hodgkin's Lymphoma Study Group analyzed by a parametric model of carcinogenesis
M Scholz, A Engert, J Franklin, et al.
European Journal of Medical Research
|
December 18, 1995
Use of granulocyte colony-stimulating factor (filgrastim) in the treatment of non-cytotoxic drug-induced agranulocytosis
P D Wickramanayake, C Scheid, A Josting, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 19, 2004
Solid tumors in patients treated for Hodgkin's disease: a report from the German Hodgkin Lymphoma Study Group
K Behringer, A Josting, P Schiller, et al.
Leukemia & Lymphoma
|
August 3, 2002
T-cell non-Hodgkin's lymphoma in adults: clinicopathological characteristics, response to treatment and prognostic factors
M Reiser, A Josting, M Soltani, et al.
Page
of 5
Search research articles
Search
Showing results (11-20 of 45) with videos related to
Sort By:
Page
of 5
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 17, 2000
Treatment of Hodgkin's disease: current strategies of the German Hodgkin's Lymphoma Study Group
M Sieber, U Rüffer, A Josting, et al.
Der Internist
|
February 28, 2003
[Current therapeutic strategies in Hodgkin lymphoma]
S Ansén, M Sieber, K Wingbermühle, et al.
Blood
|
August 15, 2000
Prognostic factors and treatment outcome in primary progressive Hodgkin lymphoma: a report from the German Hodgkin Lymphoma Study Group
A Josting, U Rueffer, J Franklin, et al.
Annals of Hematology
|
September 12, 2002
A randomized trial of chemotherapy with carmustine, etoposide, cytarabine, and melphalan (BEAM) plus peripheral stem cell transplantation (PBSCT) vs single-agent high-dose chemotherapy followed by BEAM plus PBSCT in patients with relapsed Hodgkin's disease (HD-R2)
J-P Glossmann, A Josting, B Pfistner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 19, 2000
Treatment of primary progressive Hodgkin's and aggressive non-Hodgkin's lymphoma: is there a chance for cure?
A Josting, M Reiser, U Rueffer, et al.
Pediatric Research
|
November 1, 1995
Bone marrow fibroblasts from children with aplastic anemia exhibit reduced interleukin-6 production in response to cytokines and viral challenge
D Dilloo, R Vöhringer, A Josting, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 20, 2010
Impact of first- and second-line treatment for Hodgkin's lymphoma on the incidence of AML/MDS and NHL--experience of the German Hodgkin's Lymphoma Study Group analyzed by a parametric model of carcinogenesis
M Scholz, A Engert, J Franklin, et al.
European Journal of Medical Research
|
December 18, 1995
Use of granulocyte colony-stimulating factor (filgrastim) in the treatment of non-cytotoxic drug-induced agranulocytosis
P D Wickramanayake, C Scheid, A Josting, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 19, 2004
Solid tumors in patients treated for Hodgkin's disease: a report from the German Hodgkin Lymphoma Study Group
K Behringer, A Josting, P Schiller, et al.
Leukemia & Lymphoma
|
August 3, 2002
T-cell non-Hodgkin's lymphoma in adults: clinicopathological characteristics, response to treatment and prognostic factors
M Reiser, A Josting, M Soltani, et al.
Page
of 5